ZVRA

ZEVRA THERAPEUTICS, INC.

Healthcare · Biotechnology

$155.16 sample

-1.43 (-0.91%) 1D

Market cap

$740.1B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-04

Alerts

8

Price$155.16 +3.51% 3M daily closessample

161.11147.51

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: Director
Sep 25INSInsider sell: Chief Financial Officer
Sep 18INSInsider sell: EVP, Operations
Sep 11INSInsider buy: 10% owner
Sep 04SECDEF 14A filed
Aug 27INSInsider sell: 10% owner
Aug 18INSInsider buy: General Counsel
Aug 12INSInsider buy: General Counsel

Sign up to see the real ZVRA record →

Company facts

SEC EDGAR registration

Name: ZEVRA THERAPEUTICS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -26sample, -100 to +100
Reporting currency: USD

Who is positioning in ZVRA

sample

Insiders: 21 insider transactions over 90 days, net selling, $97.9M
Congress: 3 members traded over 90 days
Institutions · 13F: 18 funds hold $14.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$41.1B +20.0% y/y

Q4 2024Q3 2026

Inventory$23.6B +13.0% y/y

Q4 2024Q3 2026

Accounts receivable$19.2B +14.3% y/y

Q4 2024Q3 2026

Total debt$47.2B +7.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $638.2B -7.1% 3M
Sample peer B: $409.1B +10.3% 3M
Sample peer C: $684.1B -0.8% 3M
Sample peer D: $406.1B -5.9% 3M
Sample peer E: $634.6B +14.2% 3M